Outage that caused trading day cancellation is of “significant concern” to the corporate watchdog. The post ASIC to investigate if ASX is fit to hold
Auscann Group Holdings and Cannpal Animal Therapeutics should emerge from their trading halt tomorrow. Here’s why to watch… The post Look out for the Auscann
This ASX fund manager thinks that the coronavirus pandemic is making some Aussie investors very rich. Here’s how it works. The post How the pandemic
A mix of 30 blue-chip stocks offers plenty of diversity, but the consumer technology icon is currently long on potential and low on risk. The
Here’s how ResMed Inc (ASX: RMD) and 2 other shares have outperformed their sectors by miles in the past month. The post 3 shares that have
The Papyrus Australia Ltd (ASX: PPY) share price rocketed more than 26% this morning. Here’s why this company is swelling in value today. The post
Trade The World Anywhere & Anytime!
Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.
Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.
- Analysts rate these ASX 200 shares as buys
- Analysts are tipping huge gains for these small cap ASX shares
- 2 fast growth ASX shares that could be buys in December 2021
- Hold the phone! Why Telstra (ASX:TLS) could be a dividend share to buy
- Could this be a fly in the appointment for Woolworths’ (ASX:WOW) push into healthcare?